title: Effects of acrivastine, loratadine and cetirizine on histamine-induced wheal and flare responses.
abstract: It is accepted that studies evaluating histamine-induced wheal and flare reactions in the skin represent a simple and reliable method for demonstrating pharmacodynamic activity and pharmacokinetics of the H1-receptor antagonists. In this study, the effects of single oral doses of acrivastine (8 mg), loratadine (10 mg) and cetirizine (10 mg) on the histamine-induced wheal and flare reactions were compared in 60 healthy volunteers. The wheal and flare responses were produced by prick test using 1% histamine solution. Measurements were performed before the ingestion of antihistamines (baseline values) and afterwards at 15, 30, 90, 240, 360 min and 24 h. The values obtained for each antihistamine were compared with each other and with baseline values. Cetirizine was found to be superior to acrivastine and loratadine for the suppression of wheal and flare responses at 240, 360 min and 24 h (P < 0.05) and acrivastine was superior to the other two antihistamines for the suppression of flare response at 30 min (P < 0.05). Our results indicate that a single dose of cetirizine provides a more effective and long acting suppression on wheal and flare reactions in urticaria when compared to acrivastine and loratadine.
authors.affiliation: Department of Dermatology, Faculty of Medicine, University of Kocaeli, Izmit, Turkey.
authors.forename: D
authors.initials: D
authors.lastname: Bayramgürler
authors.forename: N
authors.initials: N
authors.lastname: Bilen
authors.forename: R
authors.initials: R
authors.lastname: Apaydýn
authors.forename: L
authors.initials: L
authors.lastname: Altintaş
authors.forename: G
authors.initials: G
authors.lastname: Sal
authors.forename: S
authors.initials: S
authors.lastname: Dökmeci
authors.forename: T
authors.initials: T
authors.lastname: Utkan
mesh_terms: D000328:Adult; D017332:Cetirizine / Q000627:therapeutic use*; D018592:Cross-Over Studies; D005260:Female; D006632:Histamine; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D017336:Loratadine / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D016037:Single-Blind Method; D014311:Triprolidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014581:Urticaria / Q000188:drug therapy* / Q000209:etiology
chemical_list: D006634:Histamine H1 Antagonists; D014311:Triprolidine; D017336:Loratadine; D006632:Histamine; C043648:acrivastine; D017332:Cetirizine